COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Kentucky patients with a documented clinical need may be eligible for compounded tirzepatide.
Kentucky has significant rates of diabetes and obesity, particularly in the Appalachian eastern counties. Compounding Finder helps Kentucky residents connect with licensed pharmacies that ship statewide.
Yes. The Kentucky Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.